Cargando…

Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization

Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabatino, Jolanda, Di Salvo, Giovanni, Calcaterra, Giuseppe, Bassareo, Pier Paolo, Oreto, Lilia, Cazzoli, Ilaria, Calabrò, Maria Pia, Guccione, Paolo, Gatzoulis, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206548/
https://www.ncbi.nlm.nih.gov/pubmed/35360449
http://dx.doi.org/10.1016/j.ijcchd.2021.100186
_version_ 1783708650188046336
author Sabatino, Jolanda
Di Salvo, Giovanni
Calcaterra, Giuseppe
Bassareo, Pier Paolo
Oreto, Lilia
Cazzoli, Ilaria
Calabrò, Maria Pia
Guccione, Paolo
Gatzoulis, Michael A.
author_facet Sabatino, Jolanda
Di Salvo, Giovanni
Calcaterra, Giuseppe
Bassareo, Pier Paolo
Oreto, Lilia
Cazzoli, Ilaria
Calabrò, Maria Pia
Guccione, Paolo
Gatzoulis, Michael A.
author_sort Sabatino, Jolanda
collection PubMed
description Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions.
format Online
Article
Text
id pubmed-8206548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-82065482021-06-16 Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization Sabatino, Jolanda Di Salvo, Giovanni Calcaterra, Giuseppe Bassareo, Pier Paolo Oreto, Lilia Cazzoli, Ilaria Calabrò, Maria Pia Guccione, Paolo Gatzoulis, Michael A. International Journal of Cardiology Congenital Heart Disease Article Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions. The Authors. Published by Elsevier B.V. 2021-08 2021-06-16 /pmc/articles/PMC8206548/ /pubmed/35360449 http://dx.doi.org/10.1016/j.ijcchd.2021.100186 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sabatino, Jolanda
Di Salvo, Giovanni
Calcaterra, Giuseppe
Bassareo, Pier Paolo
Oreto, Lilia
Cazzoli, Ilaria
Calabrò, Maria Pia
Guccione, Paolo
Gatzoulis, Michael A.
Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization
title Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization
title_full Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization
title_fullStr Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization
title_full_unstemmed Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization
title_short Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization
title_sort adult congenital heart disease: special considerations for covid-19 and vaccine allocation/prioritization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206548/
https://www.ncbi.nlm.nih.gov/pubmed/35360449
http://dx.doi.org/10.1016/j.ijcchd.2021.100186
work_keys_str_mv AT sabatinojolanda adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT disalvogiovanni adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT calcaterragiuseppe adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT bassareopierpaolo adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT oretolilia adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT cazzoliilaria adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT calabromariapia adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT guccionepaolo adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT gatzoulismichaela adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization
AT adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization